ICL Clinical Trials

72 recruitingLast updated: May 13, 2026

There are 72 actively recruiting icl clinical trials across 34 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Philadelphia, Pennsylvania, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


ICL Trials at a Glance

72 actively recruiting trials for icl are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 29 trials, with the heaviest enrollment activity in New York, Philadelphia, and Boston. Lead sponsors running icl studies include ApaTech Ltd, Beijing Anzhen Hospital, and Centre Hospitalier Universitaire, Amiens.

Treatments under study

About ICL Clinical Trials

Looking for clinical trials for ICL? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ICL trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ICL clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 72 trials

Recruiting
Phase 4

Pediatric Long-Term Follow-up and Rollover Study

Neurofibromatosis Type 1GlioblastomaAnaplastic Astrocytoma+20 more
Novartis Pharmaceuticals165 enrolled55 locationsNCT03975829
Recruiting
Phase 2

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Breast NeoplasmsBreast DiseasesCDK4/6 Inhibitor+3 more
Fujian Cancer Hospital2,000 enrolled2 locationsNCT07581834
Recruiting
Phase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

HFpEF - Heart Failure With Preserved Ejection FractionFontan CirculationSingle Ventricle Heart Disease
Mayo Clinic27 enrolled1 locationNCT06762964
Recruiting
Not Applicable

Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle Flap

Dental ImplantSoft Tissue Augmentation at Dental ImplantsZygomatic Implants+5 more
Future University in Egypt4 enrolled1 locationNCT07574606
Recruiting
Phase 2

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Phase 4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

Contrast Enhanced Images vs. Non-contrast ImagesGadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images
UConn Health10 enrolled1 locationNCT06846853
Recruiting
Not Applicable

Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis

OsteoporosisFemale InfertilityNF-κB Ligand+2 more
Peter Humaidan100 enrolled1 locationNCT07546552
Recruiting
Not Applicable

Fontan Fitness Trial

Congenital Heart DiseaseSingle Ventricle
Children's Hospital of Philadelphia200 enrolled1 locationNCT06918795
Recruiting
Not Applicable

Study and Modeling of Perforator Flap Vascularization

Reconstructive Surgery Using Pedicled Perforating or Free Perforating FlapsPelvic EscharTraumatic Pathology of the Lower and/or Upper Limb
University Hospital, Montpellier20 enrolled1 locationNCT07084740
Recruiting

Repeated Examinations for Typing Pulmonary Embolism

Pulmonary Embolism (PE)Pulmonary Embolism (Diagnosis)Pulmonary Embolism Acute+2 more
Sahlgrenska University Hospital400 enrolled3 locationsNCT07491094
Recruiting

Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

Breast NeoplasmsAbemaciclibHormone Receptor-Positive Breast Cancer+4 more
Hubei Cancer Hospital60 enrolled1 locationNCT07264998
Recruiting
Phase 1

Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors

TrilaciclibCDK4/6-dependent Solid Tumors
Hebei Medical University Fourth Hospital100 enrolled1 locationNCT07490236
Recruiting

Robotic-Assisted Pedicle Screw Placement in Spine Surgery

Pedicle Screw Fixation of Spine
Uppsala University7,200 enrolled9 locationsNCT07461636
Recruiting
Not Applicable

Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging

Aortic Valve StenosisLeft Ventricle FunctionTranscatheter Aortic Valve Replacement (TAVR)
IRCCS Policlinico S. Donato190 enrolled2 locationsNCT07455292
Recruiting

Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis

ThrombosisCongenital Heart DiseaseSingle Ventricle
Boston Children's Hospital10 enrolled1 locationNCT06434207
Recruiting
Not Applicable

RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

CHFLeft Ventricle DilatedLeft Ventricle Remodeling
BioVentrix135 enrolled6 locationsNCT06813820
Recruiting

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

Intraventricular hemorrhageDeathPulmonary Hemorrhage+5 more
University Hospital, Montpellier30 enrolled1 locationNCT07273643
Recruiting
Not Applicable

Evaluation of the Accuracy of the eCential Robotics Robot in Spinal Surgery

SpineScoliosisPedicle Screw Accuracy+2 more
Centre Hospitalier Universitaire, Amiens45 enrolled1 locationNCT07421752
Recruiting

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Congenital Heart DiseaseAdult Congenital Heart DiseaseSystemic Right Ventricle+5 more
Leiden University Medical Center400 enrolled11 locationsNCT06932081
Recruiting
Phase 1

Study of SGR-1505 in Mature B-Cell Neoplasms

High-grade B-cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+23 more
Schrödinger, Inc.98 enrolled36 locationsNCT05544019